Stock listing

0Y2 Stock Price, News, Filings & Events — Inmune Bio Inc.

Selected listing: 0Y2 · TRADEGATE · EUR · DE

The 0Y2:TRADEGATE listing represents Inmune Bio Inc., a biotechnology company focused on developing therapies for neurodegenerative diseases and cancer. The company is actively engaged in advancing its innovative treatments and has been making headlines with recent clinical developments and research updates. Investors can find relevant filings and news that provide insights into Inmune Bio's progress and strategic initiatives within the biotech sector. The market context reflects a growing interest in companies that are pioneering solutions in these critical areas of healthcare.